Major shareholders: Boaz Wachtel (8.08%), Sharon Devir (4.46%), Suburban Holdings PTY Limited (4.43%), Youdim Pharmaceuticals (4.09%), JP Morgan Nominees Australia (3.92%), CST Capital PTY Ltd (2.51%), Horatio St. PTY Ltd (1.68%), HSBC Custody Nominees (Australia) Limited (1.47%)
Executive Chairman and CEO: Sharon Devir
Executive Director: Boaz Wachtel
The company is publicly traded on the Australian Stock Exchange under the ticker symbol ROO.